Journal of Lipid Research, Vol 35, 71-83, Copyright © 1994 by Lipid Research, Inc.

ARTICLES

Development of unesterified cholesterol-rich lipid particles in atherosclerotic lesions of WHHL and cholesterol-fed NZW rabbits

FF Chao, EJ Blanchette-Mackie, BF Dickens, W Gamble and HS Kruth
Section of Experimental Atherosclerosis, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.

Previously, we isolated and characterized unesterified cholesterol-rich lipid particles (UCLP) that accumulate in extracellular spaces of atherosclerotic lesions of humans and cholesterol-fed rabbits. In the present study, we examined early developing atherosclerotic lesions to determine when UCLP appear and when they become enriched in cholesterol and sphingomyelin. Cholesterol-fed NZW rabbits, which rapidly develop atherosclerotic lesions, and genetically hyperlipidemic WHHL rabbits, which develop lesions over a longer period of time, were studied. UCLP of peak density 1.04 g/ml appear as early as 4 weeks after the onset of cholesterol feeding and progressively accumulate during atherosclerotic lesion development. Beginning with their appearance and afterwards, UCLP contain a saturating level (2:1 molar ratio) of cholesterol relative to phospholipid. Whereas, early UCLP are enriched in phosphatidylcholine, with time UCLP become enriched with sphingomyelin. Another UCLP population having a peak density of 1.09 g/ml was present in control aortas and increased in amount more slowly than the d 1.04 g/ml UCLP during cholesterol feeding. The d 1.09 g/ml particles were predominantly unilamellar vesicles, the majority between 100 and 200 nm in diameter. They contained > 90% of their cholesterol in unesterified form and their ratio of unesterified cholesterol to phospholipid progressively increased from 0.6 to 1.7 during cholesterol feeding. Liposome resistance to solubilization by high density lipoproteins is known to be increased by enrichment with unesterified cholesterol and sphingomyelin. Sphingomyelin enrichment of unesterified cholesterol- rich lipid particles (UCLP) could stabilize cholesterol in a form that does not readily crystallize. However, at the same time, the early and progressive accumulation of UCLP in developing atherosclerotic lesions may limit reverse cholesterol transport and accelerate disease progression.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Ditiatkovski, B.-H. Toh, and A. Bobik GM-CSF Deficiency Reduces Macrophage PPAR-{gamma} Expression and Aggravates Atherosclerosis in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2337 - 2344. [Abstract] [Full Text] [PDF]

				A. Nilsson and R.-D. Duan Absorption and lipoprotein transport of sphingomyelin J. Lipid Res., January 1, 2006; 47(1): 154 - 171. [Abstract] [Full Text] [PDF]

				W. Guo, J. D. Morrisett, M. E. DeBakey, G. M. Lawrie, and J. A. Hamilton Quantification In Situ of Crystalline Cholesterol and Calcium Phosphate Hydroxyapatite in Human Atherosclerotic Plaques by Solid-State Magic Angle Spinning NMR Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1630 - 1636. [Abstract] [Full Text] [PDF]

				M. Mori, H. Itabe, K. Takatoku, K. Shima, J. Inoue, M. Nishiura, H. Takahashi, H. Ohtake, R. Sato, Y. Higashi, et al. Presence of Phospholipid-Neutral Lipid Complex Structures in Atherosclerotic Lesions as Detected by a Novel Monoclonal Antibody J. Biol. Chem., August 27, 1999; 274(35): 24828 - 24837. [Abstract] [Full Text] [PDF]

				H. S. Kruth, W.-Y. Zhang, S. I. Skarlatos, and F.-F. Chao Apolipoprotein B Stimulates Formation of Monocyte-Macrophage Surface-connected Compartments and Mediates Uptake of Low Density Lipoprotein-derived Liposomes into these Compartments J. Biol. Chem., March 12, 1999; 274(11): 7495 - 7500. [Abstract] [Full Text] [PDF]

				D. C. Schwenke and S. R. Behr Vitamin E Combined With Selenium Inhibits Atherosclerosis in Hypercholesterolemic Rabbits Independently of Effects on Plasma Cholesterol Concentrations Circ. Res., August 24, 1998; 83(4): 366 - 377. [Abstract] [Full Text] [PDF]

				F. Calara, P. Dimayuga, A. Niemann, J. Thyberg, U. Diczfalusy, J. L. Witztum, W. Palinski, P. K. Shah, B. Cercek, J. Nilsson, et al. An Animal Model to Study Local Oxidation of LDL and Its Biological Effects in the Arterial Wall Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 884 - 893. [Abstract] [Full Text] [PDF]

				N. Duverger, H. Kruth, F. Emmanuel, J.-M. Caillaud, C. Viglietta, G. Castro, A. Tailleux, C. Fievet, J. C. Fruchart, L. M. Houdebine, et al. Inhibition of Atherosclerosis Development in Cholesterol-Fed Human Apolipoprotein A-I–Transgenic Rabbits Circulation, August 15, 1996; 94(4): 713 - 717. [Abstract] [Full Text]

				J. R. Guyton and K. F. Klemp Development of the Lipid-Rich Core in Human Atherosclerosis Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 4 - 11. [Full Text]

				D. C. Schwenke Selective Increase in Cholesterol at Atherosclerosis-Susceptible Aortic Sites After Short-term Cholesterol Feeding Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 1928 - 1937. [Abstract] [Full Text]

				I. Maor, H. Mandel, and M. Aviram Macrophage Uptake of Oxidized LDL Inhibits Lysosomal Sphingomyelinase, Thus Causing the Accumulation of Unesterified Cholesterol–Sphingomyelin–Rich Particles in the Lysosomes : A Possible Role for 7-Ketocholesterol Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1378 - 1387. [Abstract] [Full Text]

				W.-Y. Zhang, I. Ishii, and H. S. Kruth Plasmin-mediated Macrophage Reversal of Low Density Lipoprotein Aggregation J. Biol. Chem., October 13, 2000; 275(42): 33176 - 33183. [Abstract] [Full Text] [PDF]